Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR

Annals of Clinical Biochemistry

Volumn 44, Issue 6, 2007, Pages 523-528

  Xie, Xiao Yan ^a   Yang, Xin ^a   Zhang, Jia Hua ^a   Liu, Ze Jun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE; MESSENGER RNA; ORGANIC COMPOUND; SYBR GREEN I; TELOMERASE; TERT PROTEIN, HUMAN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; URINALYSIS; AGED; BLADDER TUMOR; CELL CULTURE; EVALUATION; GENE EXPRESSION; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; REFERENCE VALUE; STANDARD; TUMOR EMBOLISM; URINE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM STAGING; ORGANIC CHEMICALS; POLYMERASE CHAIN REACTION; PROGNOSIS; REFERENCE VALUES; RNA, MESSENGER; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 40349095032     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456307782268093     Document Type: Article

References (23)

1. Raab SS, Lenel JC, Cohen MB. Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis. Cancer 1999; 74: 1621-6
2. Ramakumar S, Bhuiyan J, Besse JA, et al. Comparison of screening methods in the detection of bladder cancer. J Urol 1999; 161: 388-94
3. Yoshida K, Sugino T, Tahara H, et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 1997; 79: 362-9
4. Schneider-Stock R, Epplen JT, Walter H, et al. Telomeric lengths and telomerase activity in liposarcomas. Mol Carcinog 1999; 24: 144-51
5. Bieche I, Nogues C, Paradis V, et al. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 2000; 6: 452-9
6. Schneider-Stock R, Emrich T, Peters B, et al. Analysis of human telomerase reverse transcriptase mRNA (hTERT) expression in myxoid liposarcomas using LightCycler real-time quantitative reverse transcriptase-polymerase chain reaction. Electrophoresis 2001; 22: 1098-101
7. Mostofi FK, Sobin LH, Torloni H. Histologic typing of urinary bladders. In International histological classification of tumors. Geneva: World Health Organization, 1973, 36pp
8. Spiessl B, Beahrs OH, Hermanek P, Hutter RV, Scheibe O, Sobin LH. In: TNM atlas: illustrated guide to the TNM classification of malignant tumors, 3rd edition 2nd revision. Berlin: Springer-Verlag, 1992
9. Lin Y, Miyamoto H, Fujinami K, et al. Telomerase activity in human bladder cancer. Clin Cancer Res 1996; 2: 929-32
10. Kinoshita H, Ogawa O, Kakehi Y, et al. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst 1997; 89: 724-30
11. Kavaler E, Landman J, Chang Y, et al. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer 1998; 82: 708-14
12. Heine B, Hummel M, Muller M, et al. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine. J Pathol 1998; 184: 71-6
13. Yokota K, Kanda K, Inoue Y, et al. Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma. Br J Urol 1998; 82: 727-32
14. Rahat MA, Lahat N, Gazawi H, et al. Telomerase activity in patients with transitional cell carcinoma: a preliminary study. Cancer 1999; 85: 919-24
15. Gelmini S, Crisci A, Salvadori B, et al. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay. Clin Cancer Res 2000; 6: 2771-6
16. de Kok JB, van Balken MR, Roelofs RW, et al. Quantification of hTERT mRNA and telomerase activity in bladder washings of patients with recurrent urothelial cell carcinomas. Clin Chem 2000; 46: 2003-7
17. Longchampt E, Lebret T, Molinie V, et al. Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas. BJU Int 2003; 91: 567-72
18. Gibellini D, Vitone F, Schiavone P, et al. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique. J Clin Virol 2004; 29: 282-9
19. Wittwer CT, Herrmann MG, Moss AA, et al. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 1997; 22: 130-1, 134-8
20. Schmittgen TD, Zakrajsek BA, Mills AG, et al. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 2000; 285: 194-204
21. Weikert S, Krause H, Wolff I, et al. Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer. Int J Cancer 2005; 117: 274-80
22. Hotakainen K, Lintula S, Stenman J, et al. Detection of messenger RNA for the beta-subunit of chorionic gonadotropin in urinary cells from patients with transitional cell carcinoma of the bladder by reverse transcription-polymerase chain reaction. Int J Cancer 1999; 84: 304-8
23. Takihana Y, Tsuchida T, Fukasawa M, et al. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer. Int J Urol 2006; 13: 401-8